UCPH:BII Life Science Innovation Award 2025
The Faculty of Health and Medical Sciences (SUND) will present the UCPH:BII Life Science Innovation Award 2025 to celebrate the innovative minds and entrepreneurial spirit of early career life science researchers at UCPH.
In October 3 finalists will be chosen by a selection committee to present the results of their current research projects at SUND Innovation Day on 20 October.
All 3 finalists will be awarded prizes to support their future development:
- 1st prize: 25.000 DKK
- 2nd prize: 15.000 DKK
- 3rd prize: 10.000 DKK
The prizes are generously sponsored by the BioInnovation Institute (BII).
Who can nominate their project
Master's students, PhD students, Postdocs and Assistant professors from UCPH currently working on a research project within the field of Life Science. Applicants must have a prominent role in the development of the active research project described in their application and be able to present data and innovative results that have been achieved through the research project.
How and when to apply
You can nominate your project no later than 14 September by filling out the form below.
Your application must describe an ongoing research project that:
- addresses an unmet need and has a clear societal impact
- challenges existing paradigms by employing novel and innovative methodologies or concepts, and/or by pursuing an original question
- is scientifically credible and has a plan for further commercialization
- has reached a stage where results have been achieved and can be presented.
A signed approval from a supervisor or group leader must be uploaded with the application.
Timeline
- Application deadline: 14 September
- Answer to applicants: By 3 October
- Pitch training for finalists: 8 October
- Announcement of winners and celebration: 20 October at SUND Innovation Day 2025
Evaluation criteria
- Quality: The project is reliable, valid, credible, and scientifically rigorous. Moreover, the candidate is able to communicate the project and its results clearly and convincingly.
- Impact: The work should address an unmet need and have a clear societal impact. The work should challenge existing paradigms, employ innovative methodologies or concepts, and/or pursue an original question.
- Feasibility: The proposed plan for further commercialization of the project is well-thought-out, relevant, and convincing.
Selection commitee
- Kristian Strømgaard (chair), Professor at UCPH and Co-founder & CEO of Avilex Pharma
- Ruth Frikke-Schmidt, Clinical Professor at UCPH
- Zach Gerhart-Hines, Associate Professor at UCPH
- Markus J. Herrgård, CTO at BII, Science & Tech
- Lene Gerlach, Venture Partner at Hadean Ventures
- Paul Kristjansen, Senior Scientific Director at Lundbeck Foundation
Fill out this form to submit your project
Fields marked with * are required.